Recent articles

An elevated LDL-cholesterol concentration is one of the risk factors for atherosclerotic vascular disease that can be modified by lifestyle interventions or medication. Due to their greatly elevat ...

Summary The polypill, a combination therapy to prevent cardiovascular diseases like myocardial infarction, does not yet appear to be a wonder drug. Research into primary prevention using a polypi ...

The first of a series of three articles on the influence of drugs on the thyroid gland discusses the influence that drugs can have on the findings of laboratory assessments of thyroid values. It p ...

As a consequence of the publication of a number of randomised studies, Semaglutide has recently received much publicity as a possible treatment of obesity. In the Netherlands, semaglutide had been ...

This article discusses the results of the published randomised studies into the effect of corticosteroids in hospitalised patients with COVID-19. The RECOVERY study found a reduction of mortality ...

Several years after the introduction of the direct oral anticoagulants (DOACs), two specific antidotes were authorised. Idarucizumab reverses the action of the direct thrombin inhibitor dabigatran ...

Is it advisable to prescribe a low dose of colchicine (0.5 mg a day) as part of the secondary prevention of coronary heart disease? Several studies have assessed the efficacy of colchicine for thi ...

A number of monoclonal antibodies have been developed for use in patients infected with SARS-CoV-2. Clinical research has shown that these monoclonal antibodies inhibit viral replication in recent ...